LEP and obesity disorder: Knowledge of the complex biological molecular network of leptin-signaling responsible for mammary carcinogenesis within tumor microenvironment provides a strong rationale for developing new agents, tailored to target the leptin and its receptor pathways, for therapeutic intervention in breast cancer treatment, particularly in women with obesity.